Do low-risk CVD patients with T2DM experience the same significantly lower all-cause and CV mortality seen in high-risk patients?
Are you a US-based MD who sees patients with diabetes and likes to write? Why not blog for EndocrinologyNetwork.com? Be heard on topics that keep you up at night. Contact us here and we can send you the details.